CStone Pharmaceuticals (2616.HK)

HKD 2.39

(-6.64%)

Revenue Summary of CStone Pharmaceuticals

CStone Pharmaceuticals's latest annual revenue in 2023 was 463.84 Million CNY , down -3.64% from previous year.
CStone Pharmaceuticals's latest quarterly revenue in 2024 Q1 was 127.08 Million CNY , up 25.6% from previous quarter.
CStone Pharmaceuticals reported a annual revenue of 481.36 Million CNY in annual revenue 2022, up 97.51% from previous year.
CStone Pharmaceuticals reported a annual revenue of 243.71 Million CNY in annual revenue 2021, down -76.54% from previous year.
CStone Pharmaceuticals reported a quarterly revenue of 127.08 Million CNY for 2024 Q1, up 25.6% from previous quarter.
CStone Pharmaceuticals reported a quarterly revenue of 463.84 Million CNY for 2023 FY, down -3.64% from previous quarter.

Annual Revenue Chart of CStone Pharmaceuticals (2023 - 2016)

Historical Annual Revenue of CStone Pharmaceuticals (2023 - 2016)

Year	Revenue	Revenue Growth
2023	463.84 Million CNY	-3.64%
2022	481.36 Million CNY	97.51%
2021	243.71 Million CNY	-76.54%
2020	1.03 Billion CNY	0.0%
2019	- CNY	-100.0%
2018	12.55 Million CNY	21.84%
2017	10.3 Million CNY	0.0%
2016	- CNY	0.0%

Year	Revenue	Revenue Growth
2024 Q2	127.08 Million CNY	0.0%
2024 Q1	127.08 Million CNY	25.6%
2023 FY	463.84 Million CNY	-3.64%
2023 Q1	130.73 Million CNY	19.07%
2023 Q3	101.18 Million CNY	-22.6%
2023 Q2	130.73 Million CNY	0.0%
2023 Q4	101.18 Million CNY	0.0%
2022 Q4	109.79 Million CNY	0.0%
2022 FY	481.36 Million CNY	97.51%
2022 Q3	109.79 Million CNY	-16.11%
2022 Q2	130.88 Million CNY	0.0%
2022 Q1	130.88 Million CNY	59.35%
2021 Q4	82.13 Million CNY	0.0%
2021 Q3	82.13 Million CNY	106.76%
2021 FY	243.71 Million CNY	-76.54%
2021 Q1	39.72 Million CNY	-92.35%
2021 Q2	39.72 Million CNY	0.0%
2020 Q2	- CNY	0.0%
2020 Q3	519.41 Million CNY	0.0%
2020 FY	1.03 Billion CNY	0.0%
2020 Q4	519.41 Million CNY	0.0%
2020 Q1	- CNY	100.0%
2019 Q3	-867 Thousand CNY	-200.0%
2019 FY	- CNY	-100.0%
2019 Q4	-867 Thousand CNY	0.0%
2019 Q1	867 Thousand CNY	-91.17%
2019 Q2	867 Thousand CNY	0.0%
2018 Q1	1.37 Million CNY	-86.66%
2018 FY	12.55 Million CNY	21.84%
2018 Q4	9.81 Million CNY	0.0%
2018 Q3	- CNY	-100.0%
2018 Q2	1.37 Million CNY	0.0%
2017 FY	10.3 Million CNY	0.0%
2017 Q4	10.3 Million CNY	0.0%
2016 FY	- CNY	0.0%

Peer Revenue Comparison of CStone Pharmaceuticals

Name	Revenue	Revenue Difference
Uni-Bio Science Group Limited	484.71 Million HKD	4.307%
CK Life Sciences Int'l., (Holdings) Inc.	5.32 Billion HKD	91.286%